Evofem earnings
WebGet the latest Evofem Biosciences Inc EVFM stock forecast and financial predictions, including earnings and sales forecast, on TipRanks.com. Top Stocks. Top Analyst Stocks Top Smart Score Stocks Top Insiders Stocks. ... Evofem price target lowered to $2 from $30 at Piper Sandler Evofem price target lowered to $2 from $30 at Piper Sandler. WebAug 4, 2024 · Welcome to the Evofem Biosciences' Q2 conference call. If you haven't done so already, I encourage you to access the Q2 2024 presentation and the press release we issued earlier today, both of ...
Evofem earnings
Did you know?
WebNov 9, 2024 · Thank you for joining us this afternoon. In the second half of 2024 Evofem has achieved three significant milestones. In September, we launched Phexxi, the first and only non-hormonal prescription ... Web1 day ago · Look out for EVFM's next earnings release expected on March 02, 2024. For the next earning release, we expect the company to report earnings of -$0.15 per share, …
WebApr 11, 2024 · Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an … WebApr 10, 2024 · Evofem’s latest round of blood-letting will cut about $4.3 million in expenses, buying her company another few months of operating budget, while she keeps searching for a buyer or investor or ...
WebApr 11, 2024 · Evofem Biosciences Stock Earnings Report Current P/E ratio: -0.0018 Price (Apr 11, 2024, EOD): $0.0208 (Find current average P/E ratios for all sectors below … WebMay 7, 2024 · Evofem Biosciences, Inc. (OTCQB:EVFM) Q1 2024 Earnings Conference Call May 6, 2024 4:30 PM ETCompany ParticipantsAmy Raskopf - Vice President of Investor RelationsSaundra Pelletier - Chief...
Web6 minutes ago · Evofem Biosciences, Inc., is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health. The Company's first FDA-approved product, Phexxi® (lactic acid, citric acid and potassium bitartrate), is a hormone-free, on-demand prescription contraceptive vaginal gel.
WebEarnings. Loading ... Investor. Loading ... Financials. Loading ... Insiders. Loading ... Watchlist. Add. ... Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company. It is ... culligan mineral boost cartridgeWebAbout Earnings Date. Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast … culligan military discountWebApr 6, 2024 · EVOFEM BIOSCIENCES, INC. company earnings calendar and analyst expectations - Upcoming and past events OTC Markets: EVFM OTC Markets ... Q1 2024 Earnings Release: 05/04/22 11:00am : Annual General Meeting: 03/31/22 : Academy of Managed Care Pharmacy Meeting: Past dividends on EVOFEM BIOSCIENCES, INC. culligan melbourneWeb6 minutes ago · Evofem Biosciences, Inc., is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health. The … culligan mineral boost filterWebAug 11, 2024 · Shares of Evofem Biosciences (NASDAQ:EVFM) decreased 2.7% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 30.77% over the past year to ... culligan medallist water softener settingsWebMar 3, 2024 · Evofem Biosciences Inc. (EVFM) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. culligan mid atlantic.comWebAug 4, 2024 · Evofem continues to expect net product sales in the range of $30 to $35 million for its 2024 fiscal year, representing 264% to 325% growth year-over-year. Gross … culligan mid atlantic